NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









KAICO Ltd.

KAICO Ltd.

Private
FukuokaHealthcare & Life Scienceshttps://www.kaicoltd.jp/en/

Last Round

Series B

Apr 15, 2025

Est. Valuation

$18.39M

Total Funding Raised

$10.67M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

KAICO Ltd. is a biotechnology company that specializes in developing and manufacturing proteins, vaccines, and diagnostics using a proprietary silkworm-based production platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Pharma Supply Chain, D2C Brands

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

recombinant protein productionsilkworm-baculovirus expression systemdifficult-to-express proteinssilkworm bioreactorscustom protein expressionvaccine developmentcontract development and manufacturing organizationCDMOcontract research organizationCRObiomanufacturingcustom-made reagentsdrug discoverydiagnostic agentsinsect cell expressionanimal healthfeed additives

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

KAICO Ltd. Comparables

Compare KAICO Ltd. with similar companies based on industry and business-model similarity.

KAICO Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Seteka Corporation
82%
Baiya Phytopharm
75%
GenScript
74%

KAICO Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BApr 15, 2025
Series A ExtensionJan 19, 2024
Series A ExtensionDec 15, 2021
Series AMay 22, 2020
SeedOct 1, 2018

Key People

Founding team and executive leadership

Masahiro Taniguchi

Director, Chief Technology Officer(CTO)

Executive Team

KAICO Ltd. Investors

Notable investors and investment history

KAICO Ltd. investors
InvestorRounds
ITOCHU Technology VenturesSeries A Extension, Series B
Mizuho CapitalSeries A Extension
Higin CapitalSeries B
株式会社FFGベンチャービジネスパートナーズSeries A Extension, Series A, Seed
DG IncubationSeries B
Tokyo CenturySeries A Extension, Series A, Series B
株式会社佐銀キャピタル&コンサルティングSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 26, 2026

    Partnered with Reber Genetics to distribute KAICO Powder in Taiwan.

  • Nov 11, 2025

    Will exhibit at the 11th Asia Pig Veterinary Society Congress in November 2025.

KAICO Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

KAICO Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about KAICO Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersFukuoka
Employee Range11
Year Founded2018
Last FundingApr 15, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.